News and Updates

Tag: FDA

NeuroBlate System

NeuroBlate Timeline of Key Events

  April 1, 2013 – FDA cleared the NeuroBlate System for use in the U.S. It’s important to note that the NeuroBlate System was never approved by the FDA. Instead, it was merely “cleared” by the 510(k) process, meaning the FDA permitted Monteris to market the device because it was substantially equivalent to a device…

Read more
Advertising Letters

FDA Sends Far Fewer Advertising Letters in 2017

The U.S. Food and Drug Administration (FDA) is responsible for policing all prescription and over the counter medications and medical devices. The agency ensures devices and drugs comply with mandated safety standards and ensures manufacturers abide by advertising rules. Unfortunately, the FDA sent far fewer advertising letters out this past year.

Read more
Drug Inspections

FDA Paves The Way For More Drug Inspections Overseas

There is a fine balance between providing lifesaving medicine to the public and protecting the public from potentially harmful medicine. This is the line the U.S. Food and Drug Administration (FDA) must walk as it regulates drugs and medical devices. However the agency is making tremendous strides in patient safety by allowing more drug inspections in manufacturing facilities overseas.

Read more
FDA Approved Medications

One-Third of All FDA Approved Medications Pose Safety Risks

As patients, we expect the prescriptions our doctors give us to be safe to take. However, a recent study found this might not be the case. Researchers determined one out of every three medications poses additional safety risks after approval from the U.S. Food and Drug Administration (FDA).

Read more